This company has been marked as potentially delisted and may not be actively trading.

NYSE:SEM

Select Medical (SEM) Stock Price, News & Analysis

Select Medical logo

About Select Medical Stock (NYSE:SEM)

Key Stats

Today's Range
$16.51
▼
$16.51
50-Day Range
$16.50
▼
$16.67
52-Week Range
$11.65
▼
$16.99
Volume
N/A
Average Volume
3.48 million shs
Market Capitalization
$2.05 billion
P/E Ratio
15.58
Dividend Yield
1.51%
Price Target
$16.50
Consensus Rating
Hold

Company Overview

Select Medical is a leading provider of specialized healthcare services in the United States, operating through two primary business segments: Hospital Division and Outpatient Rehabilitation Division. The Hospital Division offers long-term acute care (LTAC) hospitals and inpatient rehabilitation facilities (IRFs) that serve patients recovering from complex illnesses, trauma or surgery. The Outpatient Rehabilitation Division delivers physical, occupational and speech therapy services through a network of clinic locations and home-based care programs.

Headquartered in Mechanicsburg, Pennsylvania, Select Medical was founded in 1996 and has grown through strategic partnerships, joint ventures and acquisitions. In 2013, the company completed the spin-off of its real estate assets into a separate publicly traded real estate investment trust, enabling Select Medical to focus on clinical operations while maintaining long-term facility relationships. Over the years, Select Medical has collaborated with leading health systems and academic medical centers to expand its post-acute care offerings.

Today, Select Medical’s combined network includes more than 130 hospitals and nearly 1,600 outpatient rehabilitation clinics across over 30 states. Its facilities provide specialized services such as ventilator weaning, stroke and neurological recovery, orthopedic and cardiac rehabilitation, and workplace injury recovery. The company’s outpatient clinics serve patients of all ages and conditions with evidence-based therapy programs designed to restore function and promote independence.

Under the leadership of President and CEO J. David Chernow, Select Medical has emphasized clinical quality, patient experience and operational efficiency. The executive team continues to pursue growth through targeted acquisitions, strategic alliances and the integration of new care models, with an ongoing commitment to serving the needs of patients, families and referral partners across the continuum of post-acute care.

AI Generated. May Contain Errors.

Receive SEM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Select Medical and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

SEM Stock News Headlines

Select Medical Holdings Corporation
The investigation Porter spent tens of thousands to document
Porter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experiment called Project Prophet - and documented everything on film. Rooted in the laws of physics, this quantitative approach challenges conventional wealth-building wisdom. With 17 years of verified data behind it, Porter calls it unlike anything he has seen in nearly 30 years in the business.tc pixel
See More Headlines

SEM Stock Analysis - Frequently Asked Questions

Select Medical Holdings Corporation (NYSE:SEM) issued its quarterly earnings data on Thursday, April, 30th. The health services provider reported $0.36 EPS for the quarter, missing the consensus estimate of $0.43 by $0.07. Select Medical's revenue for the quarter was up 5.0% on a year-over-year basis.
Read the conference call transcript
.

Select Medical's Board of Directors initiated a stock buyback plan on Thursday, February 19th 2026, which allows the company to buy back $1 billion in shares, according to EventVestor. This means that the company could repurchase up to 49.5% of its stock through open market purchases. Stock buyback plans are generally an indication that the company's board of directors believes its shares are undervalued.

The following companies are subsidiaries of Select Medical: AbsoluteCVO, ACC Capital, Actra Rehabilitation Associates, Advantage Rehabilitation Clinics, Alexandria Sports, Allevant Solutions, Ambulatory Care Solutions, and more.

Select Medical (SEM) raised $400 million in an initial public offering on Friday, September 25th 2009. The company issued 33,333,333 shares at $11.00-$13.00 per share.

Based on aggregate information from My MarketBeat watchlists, some other companies that Select Medical investors own include NVIDIA (NVDA), Johnson & Johnson (JNJ), Advanced Micro Devices (AMD), Boeing (BA), Salesforce (CRM), Intel (INTC) and Walmart (WMT).

Company Calendar

Today
11/19/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NYSE
Industry
Healthcare Providers & Services
Sub-Industry
Healthcare Facilities
Current Symbol
NYSE:SEM
CIK
1320414
Employees
45,300
Year Founded
1996

Price Target and Rating

High Price Target
$16.50
Low Price Target
$16.50
Potential Upside/Downside
-0.1%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
5 Analysts

Profitability

EPS (Trailing Twelve Months)
$1.06
Trailing P/E Ratio
15.58
Forward P/E Ratio
11.55
P/E Growth
0.95
Net Income
$146.22 million
Net Margins
2.42%
Pretax Margin
4.68%
Return on Equity
6.62%
Return on Assets
2.30%

Debt

Debt-to-Equity Ratio
0.88
Current Ratio
1.15
Quick Ratio
1.15

Sales & Book Value

Annual Sales
$5.52 billion
Price / Sales
0.37
Cash Flow
$2.34 per share
Price / Cash Flow
7.06
Book Value
$16.29 per share
Price / Book
1.01

Miscellaneous

Outstanding Shares
123,943,000
Free Float
104,063,000
Market Cap
$2.05 billion
Optionable
Optionable
Beta
1.01

Social Links

7 Blue-Chip Stocks to Add To Your Forever Portfolio Cover

A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.

This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.

Get This Free Report

This page (NYSE:SEM) was last updated on 7/1/2026 by MarketBeat.com Staff.
From Our Partners